Organogenesis Holdings Inc. raised $130 million by issuing 130,000 shares of Series A Convertible Preferred Stock and will use part of the proceeds to repurchase 7.4 million shares of its common stock at $3.1597 each, while also amending its credit agreement to facilitate these transactions.